Efficacy of Oral Ribavirin in Lung Transplant Patients With Respiratory Syncytial Virus Lower Respiratory Tract Infection

BACKGROUND: Respiratory syncytial virus (RSV) can cause severe lower respiratory tract infection (LRI) and is a risk factor for the development of bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx). Currently, the most widely used therapy for RSV is inhaled ribavirin. However,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pelaez, Andres, Lyon, G. Marshall, Force, Seth D., Ramirez, Allan M., Neujahr, David C., Foster, Marianne, Naik, Priyumvada M., Gal, Anthony A., Mitchell, Patrick O., Lawrence, E. Clinton
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3395057/
https://ncbi.nlm.nih.gov/pubmed/19134533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.healun.2008.10.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados